Expression of immunohistochemical markers according to histological type in patients with early gastric cancer

References

• Wu CY, Yeh HZ, Shih RT, Chen GH. A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis. Cancer 1998;83:1312–18.
   PubMed Web of Science ®Google Scholar
• Park JM, Jang YJ, Kim JH, Park SS, Park SH, Kim SJ, et al. Gastric cancer histology: clinicopathologic characteristics and prognostic value. J Surg Oncol 2008;98:520–5.
   PubMed Web of Science ®Google Scholar
• Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 2000;89:1418–24.
   PubMed Web of Science ®Google Scholar
• de Manzoni G, Roviello F, Marrelli D, Morgagni P, Di Leo A, Saragoni L, et al. [Influence of histologic type on prognosis of patients undergoing curative intervention for gastric adenocarcinoma. Italian multicenter study]. Ann Ital Chir 2001;72:13–18.
   PubMedGoogle Scholar
• Ohno S, Fujii T, Ueda S, Nakamoto T, Kinugasa S, Yoshimura H, et al. Predictive factors and timing for liver recurrence after curative resection of gastric carcinoma. Am J Surg 2003;185:258–63.
   PubMed Web of Science ®Google Scholar
• Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31–49.
   PubMedGoogle Scholar
• Bosman FT C F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Fourth Edition. WHO Classification of Tumours. International Agency for Research on Cancer (IARC), Lyon, France; 2010.
   Google Scholar
• Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surg 2002;89:236–44.
   PubMed Web of Science ®Google Scholar
• Stoeltzing O, McCarty MF, Wey JS, Fan F, Liu W, Belcheva A, et al. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004;96:946–56.
   PubMed Web of Science ®Google Scholar
• Mizokami K, Kakeji Y, Oda S, Irie K, Yonemura T, Konishi F, et al. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 2006;94:149–54.
   PubMed Web of Science ®Google Scholar
• Kim DH, Shin N, Kim GH, Song GA, Jeon TY, Kim DH, et al. Mucin expression in gastric cancer: reappraisal of its clinicopathologic and prognostic significance. Arch Pathol Lab Med 2013;137:1047–53.
   PubMed Web of Science ®Google Scholar
• Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol 1995;57:607–34.
   PubMed Web of Science ®Google Scholar
• Tsuji N, Ishiguro S, Mano M, Kasugai T, Nishizawa Y, Nose K, et al. Time trends for small gastric cancer in Japan. Gastric Cancer 2000;3:123–7.
   PubMedGoogle Scholar
• Yao T, Utsunomiya T, Oya M, Nishiyama K, Tsuneyoshi M. Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features. World J Gastroenterol 2006;12:2510–16.
   PubMed Web of Science ®Google Scholar
• Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR, et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 2005;23:3697–705.
   PubMed Web of Science ®Google Scholar
• Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, et al. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer. Hum Pathol 2002;33:105–10.
   PubMed Web of Science ®Google Scholar
• Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 2001;61:212–20.
   PubMed Web of Science ®Google Scholar
• Victorzon M, Nordling S, Haglund C, Lundin J, Roberts PJ. Expression of p53 protein as a prognostic factor in patients with gastric cancer. Eur J Cancer 1996;32a:215–20.
   PubMed Web of Science ®Google Scholar
• Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, et al. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 2008;452:525–34.
   PubMed Web of Science ®Google Scholar
• Iwamoto J, Mizokami Y, Ito M, Shomokobe K, Hirayama T, Honda A, et al. Clinicopathological features of undifferentiated mixed type early gastric cancer treated with endoscopic submucosal dissection. Hepatogastroenterology 2010;57:185–90.
   PubMed Web of Science ®Google Scholar
• Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000;89:724–32.
   PubMed Web of Science ®Google Scholar
• Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int 2004;54:311–21.
   PubMed Web of Science ®Google Scholar
• Egashira Y, Shimoda T, Ikegami M. Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 1999;49:55–61.
   PubMed Web of Science ®Google Scholar
• Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265–72.
   PubMed Web of Science ®Google Scholar
• Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, et al. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000;191:257–63.
   PubMed Web of Science ®Google Scholar
• Fiocca R, Luinetti O, Villani L, Mastracci L, Quilici P, Grillo F, et al. Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype. Hepatogastroenterology 2001;48:1523–30.
   PubMed Web of Science ®Google Scholar
• Kabashima A, Yao T, Maehara Y, Tsuneyoshi M. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas. Gastric Cancer 2005;8:220–7.
   PubMedGoogle Scholar
• Tajima Y, Yamazaki K, Makino R, Nishino N, Aoki S, Kato M, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006;12:6469–79.
   PubMed Web of Science ®Google Scholar
• Ascano JJ, Frierson HJr, Moskaluk CA, Harper JC, Roviello F, Jackson CE, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol 2001;14:942–9.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Ringnes E, Nordbo H, Sordal O, Nordrum IS, Hauso O. The normal neuroendocrine cells of the upper gastrointestinal tract lack E-cadherin. Scand J Gastroenterol 2014;49:974–8.
   PubMed Web of Science ®Google Scholar
• Hanaoka N, Tanabe S, Mikami T, Okayasu I, Saigenji K. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection. Endoscopy 2009;41:427–32.
   PubMed Web of Science ®Google Scholar
• Nakata K, Nagai E, Miyasaka Y, Ohuchida K, Ohtsuka T, Toma H, et al. The risk of lymph node metastasis in mucosal gastric carcinoma: especially for a mixture of differentiated and undifferentiated adenocarcinoma. Hepatogastroenterology 2012;59:1855–8.
   PubMed Web of Science ®Google Scholar
• Igarashi N, Takahashi M, Ohkubo H, Omata K, Iida R, Fujimoto S. Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma. Cancer 1999;86:1449–54.
   PubMed Web of Science ®Google Scholar